Equities

Adicon Holdings Ltd

Adicon Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)6.24
  • Today's Change-0.17 / -2.65%
  • Shares traded343.00k
  • 1 Year change-37.97%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Adicon Holdings Ltd is an investment holding company principally engaged in the provision of independent clinical laboratory (ICL) services. The Company primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The Company's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The Company is also engaged in the sales of medical testing equipment. The Company principally conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)3.35bn
  • Net income in HKD241.33m
  • Incorporated2008
  • Employees5.46k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Suzhou Basecare Medical Corp Ltd265.51m-268.79m932.72m528.00--0.6817--3.51-0.9827-0.98270.97075.000.13141.521.55453,084.30-13.33-36.68-14.80-39.8746.8043.17-101.46-315.785.14--0.2099--47.6044.86-45.45--86.78--
Kindstar Globalgene Technology Inc1.02bn9.88m1.14bn3.19k112.990.355513.471.120.01040.01041.063.290.249410.091.61325,810.700.0917-21.990.1174-35.4845.6848.760.3679-49.512.743.500.1109---30.246.49-45.29--23.67--
Honliv Healthcare Management Grp Co Ltd864.98m36.62m1.19bn1.95k30.931.9810.991.380.06430.06431.511.010.825634.2212.00439,299.903.534.505.948.7318.2023.054.286.260.84448.930.23160.004.508.90-21.73-12.0366.84--
EuroEyes International Eye Clinic Ltd736.28m107.92m1.38bn365.0012.841.216.521.880.32490.32492.223.440.435524.8572.612,538,893.006.596.187.527.2042.9145.8115.1414.313.78--0.2294--17.0412.4446.6929.9134.24--
Arrail Group Ltd1.88bn18.44m1.65bn3.46k78.720.71345.630.87760.03710.03713.854.090.552924.9918.07541,370.700.4249-14.220.5856-67.5422.4919.470.7685-24.541.98--0.3643--18.4610.08107.80---9.65--
Town Health International Medical Gp Ltd1.83bn-262.95m1.65bn1.43k--0.5245--0.8992-0.0388-0.03880.27020.46330.409323.404.961,308,424.00-5.06-1.21-6.36-1.4427.8129.06-12.36-4.013.670.9850.0798--19.3710.32-1,370.26---25.95-13.65
Mega Genomics Ltd171.56m34.26m1.78bn214.0046.802.5435.4910.360.16370.16370.81423.010.203830.130.985749,177.404.07--4.67--57.99--19.97--5.42--0.0588--3.82--270.50------
Rici Healthcare Holdings Ltd3.16bn349.57m1.91bn9.65k5.461.472.560.60440.21980.21981.990.8190.667946.2311.07335,456.308.253.2414.165.7839.5237.0012.345.930.61144.720.6610.0026.0116.8556.06--2.51--
Chaoju Eye Care Holdings Ltd1.52bn230.69m2.05bn2.65k8.660.8025.551.350.3350.3352.203.620.497913.4821.16583,673.107.328.088.369.5644.9443.8114.7015.474.9526.360.071551.5738.3316.7021.9242.68-2.33--
C-Mer Medical Holdings Ltd1.90bn63.00m2.57bn2.19k40.531.388.221.360.05060.05061.521.490.69232.3037.42579,346.803.540.92374.371.1232.0629.955.111.441.8212.640.16745.3311.0934.98383.427.8128.01--
Yunkang Group Ltd853.53m-297.66m4.35bn1.46k--2.11--5.10-0.4945-0.49451.423.320.183830.130.482565,252.10-6.386.70-11.8211.1934.2742.42-34.7310.991.73-2.460.379519.89-76.278.38-127.10--33.22--
Adicon Holdings Ltd3.35bn241.33m4.65bn5.46k19.322.4210.331.390.33180.33184.612.650.662613.031.80586,531.905.22--8.80--40.93--7.87--1.916.110.4213---32.15---65.50------
China Resources Medical Holdings Com Ltd10.71bn315.76m5.03bn19.64k15.540.75914.790.46980.24980.24988.475.110.618825.756.16530,909.402.193.244.394.8018.5920.293.546.600.7904195.560.224627.9527.9237.46-3.07-9.7753.23-10.66
Data as of Nov 22 2024. Currency figures normalised to Adicon Holdings Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

4.72%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 06 Nov 202413.17m1.81%
BlackRock Advisors LLCas of 30 Jun 202410.70m1.47%
Grandeur Peak Global Advisors LLCas of 31 Jul 20244.28m0.59%
Bosera Asset Management Co., Ltd.as of 30 Jun 20242.97m0.41%
Norges Bank Investment Managementas of 30 Jun 20242.54m0.35%
Vanguard Fiduciary Trust Co.as of 31 Aug 2024354.00k0.05%
BlackRock Fund Advisorsas of 07 Nov 2024118.00k0.02%
TIAA-CREF Investment Management LLCas of 31 Aug 2024102.50k0.01%
BlackRock Advisors (UK) Ltd.as of 08 Nov 202466.00k0.01%
State Street Global Advisors Ltd.as of 07 Nov 202445.50k0.01%
More ▼
Data from 30 Jun 2024 - 14 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.